Skip to content

Preventive antibacterial short-term therapy in patients with acute ischemic infarction in the territory of the middle cerebral artery (MCA)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN74386719
Enrollment
80
Registered
2004-07-13
Start date
2003-06-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Circulatory System Stroke

Interventions

Patients of group A are being treated according to the current standards of therapy. With respect to antibiotics, they are fully and effectively treated as soon as an antibiotic medication is indicate

Sponsors

Charité - University Medicine Berlin (Charité - Universitätsmedizin Berlin) (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The double blind, randomised and controlled study will be carried out on two groups of about 40 patients each. Since patients with large infarctions in the territory of the middle cerebral artery and a subsequent severe neurological deficit (National Institutes of Health-Stroke-Scale [NIHSS] greater than 11) have the highest risk of pneumonia, we include only this subpopulation of stroke patients in our study. Inclusion criteria: 1. Severe ischemic strokes in MCA territory (area greater than 50% in cerebral computed tomography [CCT], NIHSS greater than 11) 2. Within 36 hours after stroke onset 3. Older than 18 years 4. No infection 5. No intracerebral bleeding

Exclusion criteria

Exclusion criteria: 1. Immunosupressive therapy 2. Pregnancy 3. Antibacterial therapy within the last 24 hours before inclusion 4. Contraindication for moxifloxacin

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration

Secondary

MeasureTime frame
Not provided at time of registration

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 5, 2026